
Douglas H. Jones
Articles
-
Jan 15, 2025 |
healio.com | Victoria Langowska |Kristen Dowd |Douglas H. Jones
You've successfully added Skin Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:Lanadelumab reduced median HAE attack rates by 98.8%. Over 70% of patients increased their dosing interval. The mean time to a dosing interval increase was 8.2 months.
-
Dec 2, 2024 |
healio.com | Victoria Langowska |Kristen Dowd |Douglas H. Jones |Daniel Barber
You've successfully added Asthma and Respiratory Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Healio has compiled November’s most read news in asthma and allergy.
-
Oct 2, 2024 |
healio.com | Douglas H. Jones |Kristen Dowd
You've successfully added Food Allergy to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The Teal Pumpkin Project encourages inclusion for children with food allergy. Parents can take steps to ensure safe Halloween parties.
-
Aug 26, 2024 |
healio.com | Douglas H. Jones |Kristen Dowd
You've successfully added Food Allergy to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Oral and sublingual immunotherapy can mitigate allergic reactions. Interest in how the gut microbiome impacts food allergy is growing.
-
Jul 17, 2024 |
healio.com | Victoria Langowska |Kristen Dowd |Douglas H. Jones
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Sebetralstat is the first on-demand oral therapy that would be available to patients with hereditary angioedema. New study aims to gather data on patients aged 2 to 11 years for future drug approval.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →